NovaBridge Biosciences (NBP) Equity Income (2019 - 2024)
NovaBridge Biosciences (NBP) reported Equity Income of $2.1 million for Q4 2024, down 90.58% year-over-year from $22.0 million in Q1 2024, and up 300.0% quarter-over-quarter from -$1.0 million in Q1 2024.
NovaBridge Biosciences (NBP) Equity Income (2019 - 2024) Analysis & Trends
NovaBridge Biosciences (NBP) has 4 years of Equity Income data on file, last reported at $2.1 million in Q4 2024.
- Equity Income for Q4 2024 came in at $2.1 million, down 90.58% year-over-year; the trailing twelve-month figure through Dec 2024 was $1.0 million (down 96.26% YoY), and the FY2025 annual result was $5.2 million, up 397.5% from the prior year.
- Equity Income improved to $2.1 million in Q4 2024 per NBP's latest filing, from -$1.0 million in the prior quarter.
- Over five years, Equity Income peaked at $22.0 million in Q4 2023 and troughed at -$58.8 million in Q3 2020.
- A 3-year average of -$4.3 million and a median of -$1.0 million in 2024 frame the typical range for Equity Income.
- The sharpest annual moves came in 2020 and 2024: Equity Income jumped 21498.78% in 2020, then slumped 90.58% in 2024.
- A 3-year view of Equity Income shows it stood at $10.2 million in 2020, then surged by 116.67% to $22.0 million in 2023, then tumbled by 90.58% to $2.1 million in 2024.
- Business Quant data shows NBP's Equity Income at $2.1 million in Q4 2024, -$1.0 million in Q1 2024, and $22.0 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 235,807.00 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | NovaBridge Biosciences | 328.19 Mn | 117.34 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 2.08 Mn |
| Mar 31, 2024 | -1.04 Mn |
| Dec 31, 2023 | 22.04 Mn |
| Sep 30, 2023 | -2.45 Mn |
| Jun 30, 2023 | -1.99 Mn |
| Dec 31, 2020 | 10.17 Mn |
| Sep 30, 2020 | -58.83 Mn |
| Dec 31, 2019 | 47,104.42 |